English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23368654      線上人數 : 519
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/23265


    標題: Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia
    作者: Hung-Yuan Li
    Jung-Nan Wei
    Mao-Shin Lin
    David J. Smith
    Jani Vainio
    Cheng-Hsin Line
    Fu-Tien Chiang
    Shyang-Rong Shih
    Ching-Huei Huang
    Mei-Yu Wu
    Yenh-Chen Hsein
    Lee-Ming Chuang
    貢獻者: 職業安全衛生系
    關鍵字: Semicarbazide-sensitive amine oxidase
    Vascular adhesion protein-1
    Amine oxidase
    Copper-containing 3 (AOC3)
    Diabetes mellitus
    Diabetic complications
    日期: 2009-06
    上傳時間: 2010-11-19 11:50:22 (UTC+8)
    摘要: Background
    The relationship between serum vascular adhesion protein-1 (VAP-1) and plasma glucose in normal and drug-naïve type 2 diabetes subjects is unclear. We examined if serum VAP-1 changed acutely to oral glucose loading and analyzed the relationship between serum VAP-1, fasting plasma glucose (FPG), hemoglobin A1c, and type 2 diabetes.

    Methods
    Adults without history of diabetes were included. Subjects taking anti-diabetic drugs were excluded. Serum VAP-1 was analyzed by time-resolved immunofluorometric assay.

    Results
    We recruited 333 subjects (186 females and 147 males), aged 56.1 ± 11.6 y. After glucose challenge, serum VAP-1 rose significantly at 30 min (p < 0.0001) and lasted until 2 h (p < 0.0001). The change of serum VAP-1 between fasting and 30-min postload correlated inversely to the change of plasma insulin (r = − 0.21, p = 0.049). Fasting serum VAP-1 was associated with FPG in those with FPG ≥ 5.55 mmol/l (p = 0.025) but not in those with FPG < 5.55 mmol/l (p = NS). Fasting serum VAP-1 were higher in diabetic subjects (p = 0.04) and correlated positively to hemoglobin A1c (r = 0.18, p = 0.002) after adjusting for age, gender, and waist circumference.

    Conclusions
    Serum VAP-1 is increased in both acute and chronic hyperglycemia. Whether serum VAP-1 is a good biomarker for hyperglycemia-associated complications merits further investigation.
    關聯: Clinica Chimica Acta 404(2):p.149-153
    顯示於類別:[職業安全衛生系(含防災所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1949檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋